HARP
Income statement / Annual
Last year (2022), Harpoon Therapeutics, Inc.'s total revenue was $31.92 M,
an increase of 34.92% from the previous year.
In 2022, Harpoon Therapeutics, Inc.'s net income was -$67.14 M.
See Harpoon Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$31.92 M |
$23.65 M |
$17.44 M |
$5.78 M |
$4.75 M |
$708,000.00 |
$0.00 |
| Cost of Revenue |
$3.10 M
|
$2.65 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$28.82 M
|
$21.01 M
|
$17.44 M
|
$5.78 M
|
$4.75 M
|
$708,000.00
|
$0.00
|
| Gross Profit Ratio |
0.9
|
0.89
|
1
|
1
|
1
|
1
|
0
|
| Research and Development Expenses |
$81.39 M
|
$72.12 M
|
$52.57 M
|
$41.59 M
|
$26.37 M
|
$13.62 M
|
$7.78 M
|
| General & Administrative Expenses |
$18.85 M
|
$18.33 M
|
$16.21 M
|
$22.39 M
|
$6.11 M
|
$3.61 M
|
$3.37 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$18.85 M
|
$18.33 M
|
$16.21 M
|
$22.39 M
|
$6.11 M
|
$3.61 M
|
$3.37 M
|
| Other Expenses |
-$182,000.00
|
-$210,000.00
|
-$26,000.00
|
-$42,000.00
|
-$37,000.00
|
-$17,000.00
|
-$4,000.00
|
| Operating Expenses |
$100.24 M
|
$90.45 M
|
$68.78 M
|
$63.98 M
|
$32.47 M
|
$17.24 M
|
$11.15 M
|
| Cost And Expenses |
$100.24 M
|
$90.45 M
|
$68.78 M
|
$63.98 M
|
$32.47 M
|
$17.24 M
|
$11.15 M
|
| Interest Income |
$776,000.00
|
$240,000.00
|
$1.45 M
|
$2.68 M
|
$395,000.00
|
$0.00
|
$6,000.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$285,000.00
|
$261,000.00
|
| Depreciation & Amortization |
$2.36 M
|
$102.10 M
|
$2.08 M
|
$900,000.00
|
$644,000.00
|
$366,000.00
|
$198,000.00
|
| EBITDA |
-$65.97 M |
-$14.65 M |
-$49.25 M |
-$58.21 M |
-$27.37 M |
-$16.16 M |
-$10.95 M |
| EBITDA Ratio |
-2.14
|
-0.62
|
-2.94
|
-10.08
|
-5.76
|
-22.85
|
0
|
| Operating Income Ratio |
-2.14
|
-4.94
|
-2.94
|
-10.08
|
-5.84
|
-23.34
|
0
|
| Total Other Income/Expenses Net |
$594,000.00
|
$30,000.00
|
$1.42 M
|
$2.63 M
|
$358,000.00
|
-$302,000.00
|
-$259,000.00
|
| Income Before Tax |
-$67.73 M
|
-$116.72 M
|
-$49.91 M
|
-$55.57 M
|
-$27.37 M
|
-$16.83 M
|
-$11.41 M
|
| Income Before Tax Ratio |
-2.12
|
-4.93
|
-2.86
|
-9.62
|
-5.76
|
-23.77
|
0
|
| Income Tax Expense |
-$594,000.00
|
$49.71 M
|
-$3.53 M
|
-$3.58 M
|
$358,000.00
|
$268,000.00
|
$257,000.00
|
| Net Income |
-$67.14 M
|
-$166.44 M
|
-$46.38 M
|
-$52.00 M
|
-$27.37 M
|
-$16.83 M
|
-$11.41 M
|
| Net Income Ratio |
-2.1
|
-7.04
|
-2.66
|
-9
|
-5.76
|
-23.77
|
0
|
| EPS |
-20.24 |
-51.57 |
-18.52 |
-23.91 |
-11.45 |
-17.81 |
-1.21 |
| EPS Diluted |
-20.24 |
-51.57 |
-18.52 |
-23.91 |
-11.45 |
-17.81 |
-1.21 |
| Weighted Average Shares Out |
$3.32 M
|
$3.23 M
|
$2.50 M
|
$2.17 M
|
$2.39 M
|
$944,807.00
|
$9.45 M
|
| Weighted Average Shares Out Diluted |
$3.32 M
|
$3.23 M
|
$2.50 M
|
$2.17 M
|
$2.39 M
|
$944,807.00
|
$9.45 M
|
| Link |
|
|
|
|
|
|
|
